Adagio Medical HoldingsADGM -2.30%11 EBIT per Share is $-1.22 as of Mar. 2026. GuruFocus rates ADGM with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 688 Medical Devices & Instruments companies, Adagio Medical Holdings ranks better than 50.29% on this metric.
Adagio Medical Holdings's EBIT per Share for the
three
months ended in Mar. 2026 was $-0.28.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.22.
During the past 3 years, the average EBIT per Share Growth Rate was 9.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Adagio Medical Holdings's EBIT per Share or its related term are showing as below:
ADGM'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 9.6 Med: 9.6 Max: 9.6
Current: 9.6
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Adagio Medical Holdings was 9.60% per year. The lowest was 9.60% per year. And the median was 9.60% per year.
ADGM's 3-Year EBIT Growth Rate is ranked better than 50.29% of 688
companies
in the Medical Devices & Instruments industry
Industry Median: 9.5
vs ADGM: 9.60
Adagio Medical Holdings (NAS:ADGM) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Adagio Medical Holdings EBIT per Share Related Terms
Adagio Medical Holdings EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.22
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adagio Medical Holdings (ADGM) has a EBIT per Share of $-1.22 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Adagio Medical Holdings and its competitors. According to the industry distribution chart, Adagio Medical Holdings ranks #342 out of 688 companies in the Medical Devices & Instruments industry, placing it in the top 49.7%.
Is Adagio Medical Holdings' EBIT per Share too high?
Adagio Medical Holdings' current EBIT per Share is $-1.22. Based on the distribution chart, Adagio Medical Holdings ranks #342 out of 688 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Adagio Medical Holdings has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Adagio Medical Holdings' EBIT per Share compare to VNRX and PMI?
According to the Medical Devices & Instruments industry distribution chart, Adagio Medical Holdings ranks #342 out of 688 companies for EBIT per Share. This puts Adagio Medical Holdings in the upper half of its industry. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Adagio Medical Holdings and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adagio Medical Holdings's current EBIT per Share is $-1.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adagio Medical Holdings stock overvalued right now?
Adagio Medical Holdings (ADGM) has a current EBIT per Share of $-1.22. The current EBIT per Share is $-1.22. Adagio Medical Holdings' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Adagio Medical Holdings (ADGM), the current EBIT per Share is $-1.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
11GF Score
Get the complete analysis for ADGM
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADGM has been successfully added to your 
